skip to main content

Title: Can Big Pharma Behavior Change to Benefit Patients?

Professors Rosenberg and Chu will discuss how the behavior of large pharmaceutical companies can sometimes compromise the needs of patients. The behavior includes strategies for lobbying Congress, expmore »loiting patent law, targeting large consumer markets, creating demand from patients, and influencing physicians. In some cases, this behavior has created ethical and legal problems. The talk will conclude with a discussion of possible ways to encourage changes that will benefit patients.« less
video
Title: Can Big Pharma Behavior Change to Benefit Patients?
Authors:
Publication Date: 2005-03-09
OSTI Identifier: 1014109
DOE Contract Number: AC02-76SF00515
Other Number(s): TRN: US1105429
Resource Type: Multimedia
Resource Relation: Conference: SLAC Colloquium Series, SLAC National Accelerator Laboratory, Menlo Park, California, presented on March 09, 2005
Research Org: SLAC (SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States))
Sponsoring Org: USDOE Office of Science (SC)
Subject: 43 PARTICLE ACCELERATORS ; DRUGS ; FERMILAB ACCELERATOR ; PATENT LAWS ; PATIENTS ; STANFORD LINEAR ACCELERATOR CENTER
Country of Publication: United States
Language: English
Run Time: 1:13:08
System Entry Date: 2016-01-27